When cartilage repair is the right choiceCartilage repair succeeds for a focal defect in otherwise healthy joint tissue in younger patients, but fails in diffuse arthritis. Lesion size, depth, patient age, and activity level determine the appropriate technique.Cartilage repair succeeds for a focal defect in otherwise healthy joint tissue in younger patients, but fails in diffuse arthritis. Lesion size, depth, patient age, and activity level determine the appropriate technique.
ChondroFiller injection cost and what affects itChondroFiller injection costs £3,000–£8,000 depending on cartilage defect size: one box £3,000, two boxes £5,500, three boxes £8,000, each including consultation, ultrasound guidance, implant, injection and six-week follow-up.ChondroFiller injection costs £3,000–£8,000 depending on cartilage defect size: one box £3,000, two boxes £5,500, three boxes £8,000, each including consultation, ultrasound guidance, implant, injection and six-week follow-up.
How ACI and MACI differ for cartilage repairMACI pre-seeds cultured chondrocytes onto a collagen membrane fixed with fibrin glue, eliminating the sutures required in earlier ACI variants. The technique enables arthroscopic implantation and supports faster recovery than open surgical approaches.MACI pre-seeds cultured chondrocytes onto a collagen membrane fixed with fibrin glue, eliminating the sutures required in earlier ACI variants. The technique enables arthroscopic implantation and supports faster recovery than open surgical approaches.
ChondroFiller injection vs knee replacementChondroFiller is a collagen scaffold injection that recruits the patient's own repair cells to treat focal cartilage defects. Knee replacement suits end-stage, widespread wear; the choice between them depends on imaging findings, not age.ChondroFiller is a collagen scaffold injection that recruits the patient's own repair cells to treat focal cartilage defects. Knee replacement suits end-stage, widespread wear; the choice between them depends on imaging findings, not age.
Injectable scaffold vs surgical knee cartilage repairFor focal knee cartilage defects, injectable collagen scaffolds provide a non-surgical treatment by acting as an acellular matrix that guides the patient's own progenitor cells in regenerating cartilage-like tissue, overcoming cartilage's inability to repair itself due to lacking blood supply.For focal knee cartilage defects, injectable collagen scaffolds provide a non-surgical treatment by acting as an acellular matrix that guides the patient's own progenitor cells in regenerating cartilage-like tissue, overcoming cartilage's inability to repair itself due to lacking blood supply.
AMIC versus MACI for focal cartilage repairAMIC repairs focal cartilage defects in one operation: drilling channels into damaged cartilage releases a blood clot rich in stem cells, which a collagen membrane then stabilises and concentrates to guide tissue repair. A 2025 trial found it equivalent to MACI at two years.AMIC repairs focal cartilage defects in one operation: drilling channels into damaged cartilage releases a blood clot rich in stem cells, which a collagen membrane then stabilises and concentrates to guide tissue repair. A 2025 trial found it equivalent to MACI at two years.
Chondroplasty for knee cartilage damageChondroplasty removes loose cartilage fragments that cause catching and grinding, relieving mechanical symptoms, but does not rebuild the cartilage itself; it is palliative, not restorative.Chondroplasty removes loose cartilage fragments that cause catching and grinding, relieving mechanical symptoms, but does not rebuild the cartilage itself; it is palliative, not restorative.
ChondroFiller success rates in practiceChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.ChondroFiller, which recruits a patient's own cells to fill cartilage defects, produces meaningful pain reduction and improved joint function in 70–85% of patients within one to five years; but success depends on selecting younger patients with focal defects in otherwise healthy joints.
Who benefits from an unloader knee braceUnloader braces use three-point pressure to shift load away from damaged cartilage. They work only for single-compartment osteoarthritis, and success depends more on professional fitting and follow-up than the device itself.Unloader braces use three-point pressure to shift load away from damaged cartilage. They work only for single-compartment osteoarthritis, and success depends more on professional fitting and follow-up than the device itself.
Choosing injection treatments for knee, hip and ankleHyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower…Hyaluronic acid injections can ease knee osteoarthritis pain for months, but the 2019 ACR/AF guideline recommends against routine use for knee disease and strongly against it for hip disease because average benefit is modest. Microfragmented fat and bone marrow concentrate are more experimental biologic options, with limited evidence and narrower uses in knee arthritis and talar cartilage lesions.
Arthrosamid recovery and ankle MFAT in your treatment pathwayArthrosamid is used for knee osteoarthritis and MFAT for ankle cartilage problems or ankle osteoarthritis, but the evidence differs: knee hydrogel data extend to 24 months, while ankle MFAT studies remain early and mostly observational. After Arthrosamid, soreness and swelling usually settle over 24–48 hours, with benefits building over weeks.Arthrosamid is used for knee osteoarthritis and MFAT for ankle cartilage problems or ankle osteoarthritis, but the evidence differs: knee hydrogel data extend to 24 months, while ankle MFAT studies remain early and mostly observational. After Arthrosamid, soreness and swelling usually settle over 24–48 hours, with benefits building over weeks.
Choosing advanced injection options for knee osteoarthritisArthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.Arthrosamid, a 2.5% polyacrylamide hydrogel given as a single 6 mL knee injection, is designed to stay in the joint and has extension data showing WOMAC pain improvements maintained to five years. MFAT, PRP and BMAC offer biologic alternatives, but their evidence is smaller and less consistent.